TABLE VII.
Subject number | P N | P CO | P CA | S N | S CO | S CA | U N | U CO | U CA |
---|---|---|---|---|---|---|---|---|---|
1 eight days prior to injection of 5IA | 2.80 | <10.0 | 35.5 | 4.07 | <10.0 | 23.7 | <1.0 | <10.0 | 40.2 |
1 day of injection of 5IA | 55.3 | <10.0 | 187 | 0 | 0 | 107 | <1.0 | <10.0 | 75.7 |
2 | 1.63 | 19.4 | 22.4 | 0 | 0 | <20.0 | 0 | 0 | <20.0 |
3 | 14.1 | 39.9 | 576 | 224 | 213 | 685 | 1.72 | 42.6 | 804 |
4 | <1.0 | <10.0 | 268 | <1.0 | 18.5 | 559 | 0 | <10.0 | 370 |
5 | 0 | <10.0 | 119 | 0 | <10.0 | 91.8 | 1.32 | 69.6 | 151 |
6 | 0 | <10.0 | 354 | 0 | <10.0 | 299 | 3.88 | 85.9 | 475 |
7 | 2.92 | 103 | 216 | 2.86 | 140 | 207 | 391 | 1160 | 207 |
8 | <1.0 | <10.0 | 0 | <1.0 | <10.0 | 0 | <1.0 | <10.0 | 0 |
9 | <1.0 | 71.4 | <20.0 | <1.0 | 69.5 | 0 | 172 | 532 | 0 |
10 | 0 | <10.0 | 61.9 | <1.0 | <10.0 | 157 | 8.22 | <10.0 | 140 |
11 | <1.0 | 0 | <20.0 | <1.0 | <10.0 | <20.0 | 0 | <10.0 | 25.7 |
12 | 3.20 | 153.2 | 105.4 | 37 | 163.1 | <20.0 | 172.2 | 1145.8 | 176.9 |